Trial Profile
The effect of pramlintide on meal time insulin bolus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Pramlintide (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 08 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Apr 2009 Actual end date (Nov 2008) added as reported by ClinicalTrials.gov.
- 15 Nov 2007 Status changed from initiated to in progress.